← SynDRA
NARASIN
SynDRA canonical compound SYN0030491 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | antiprotozoal agent |
| Indication | coccidiosis |
| Disease area | infectious disease |
Mechanisms of action (all sources)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antiparasitic Agents
- Antiprotozoal Agents
- Coccidiostats
Cross-references
Synonyms
- C-7819B
- compound 79891
- monteban
- Narasine
- Narasina
- Antibiotic a-28086 factor a
- Narasin a
- Salinomycin, 4-methyl-, (4s)-
- COMPD-79891
- COMPOUND 79891
- Monteban
- Narasin A
- Compound 79891
- Antibiotic A-28086 factor A
- Antibiotic C 7819B
- Antibiotic A 28086A
- Salinomycin, 4-methyl-, (4S)
- Lilly 79891
- 4-Methylsalinomycin
- C 7819B
- DZY9VU539P
- Narasino
- Narasinum
- Monteban (TN)
- Narasine [INN-French]
- Narasinum [INN-Latin]
- Narasino [INN-Spanish]
- Narasin (USP/INN)
- (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid
- UNII-DZY9VU539P
- BRN 1678311
- AI3-29798
- Narasin [USAN:USP:INN:BAN]
- Narasin 100 microg/mL in Acetonitrile
- NCGC00167550-01
- (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9
- 2H-Pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl-
- NARASIN [USAN]
Look up NARASIN in the interactive SynDRA portal →